These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7916025)

  • 1. A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma.
    Sharir M; Zimmerman TJ; del Negro RG; Ball SF; Kooner KS
    J Ocul Pharmacol; 1994; 10(2):411-20. PubMed ID: 7916025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
    Mirza GE; Karaküçük S; Temel E
    J Glaucoma; 2000 Feb; 9(1):45-50. PubMed ID: 10708231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
    Krieglstein GK; Novack GD; Voepel E; Schwarzbach G; Lange U; Schunck KP; Lue JC; Glavinos EP
    Br J Ophthalmol; 1987 Apr; 71(4):250-3. PubMed ID: 2883990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
    Simmons ST; Samuelson TW
    Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metipranolol 0.1% and pilocarpine 2% as a fixed combination compared to each substance alone in the treatment of glaucoma. A controlled, randomized clinical study comparing the intraindividual effects and tolerance].
    Scharrer A; Ober M
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):450-5. PubMed ID: 2882046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
    Diestelhorst M
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):433-9. PubMed ID: 10901475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metipranolol 0.1%: effect of a single dose on the nycthemeral pressure curve in an eye with chronic primary open-angle glaucoma].
    Demailly P; Lecherpie F
    J Fr Ophtalmol; 1987; 10(6-7):447-9. PubMed ID: 2891739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D; Maloney S; Vaccarelli L; Liss C; Wilson H; Gormley GJ
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
    Bron AM; Garcher CP; Sirbat D; Allaire CM; Lablache-Combier MJ; Trinquand CJ
    Eur J Ophthalmol; 1997; 7(4):351-6. PubMed ID: 9457458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL
    Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzalkiewicz A; Zaleska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Acta Ophthalmol Scand; 2003 Aug; 81(4):349-54. PubMed ID: 12859261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure].
    Ober M; Scharrer A; Novack GD; Lue JC
    Ophthalmologica; 1986; 192(3):159-64. PubMed ID: 2873545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
    Berlin MS; Rowe-Rendleman C; Ahmed I; Ross DT; Fujii A; Ouchi T; Quach C; Wood A; Ward CL
    Br J Ophthalmol; 2016 Jun; 100(6):843-7. PubMed ID: 26453641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.